GOLDEN, Colo.--(BUSINESS WIRE)--Vitro Diagnostics, Inc. (OTCBB: VODG), dba Vitro Biopharma, announced notification from the United States Patent Office (USPTO) indicating the successful examination of its patent application entitled, “Generation and Differentiation of Adult Stem Cells.” (App No 11/256,673) The USPTO issued an Official Notice of Allowance indicating the allowance of certain claims and the impending issuance of a new United States patent.